Beaurang Pierre
SEC CIK 1817226 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| NRIX | Nurix Therapeutics, Inc. | Chief Business Off | 11.8K | — | $403.4K | 4 | 2021-07-12 | 2021-08-10 |
Most active insiders at NRIX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Ring Christine | CLO | — | $3.26M |
| 2 | van Houte Hans | CFO | — | $635.3K |
| 3 | Hansen Gwenn | CSO | — | $630.9K |
Beaurang Pierre made no open-market trades at NRIX in the last 12 months.
Transactions 4
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-08-11 | 2021-08-10 | NRIX | Nurix Therapeutics, Inc. | Beaurang Pierre | Chief Business Off | M - OptEx | $1.11 | +7,500 | 11.8K | +173% | +$8,325 |
| DM | 2021-08-11 | 2021-08-10 | NRIX | Nurix Therapeutics, Inc. | Beaurang Pierre | Chief Business Off | S - Sale+OE | $29.86 | -7,500 | 6,210 | -55% | -$223.9K |
| DM | 2021-07-12 | 2021-07-12 | NRIX | Nurix Therapeutics, Inc. | Beaurang Pierre | Chief Business Off | S - Sale+OE | $23.93 | -7,500 | 4,730 | -61% | -$179.4K |
| D | 2021-07-12 | 2021-07-12 | NRIX | Nurix Therapeutics, Inc. | Beaurang Pierre | Chief Business Off | M - OptEx | $1.11 | +7,500 | 11.8K | +173% | +$8,325 |
Purchase Sale Sale after option exercise All abbreviations